19829-38-0

Basic information

• Product Name: Benzeneacetic acid, 2-hydroxy-, phenylmethyl ester
• Synonyms: benzyl (2-hydroxyphenyl)acetate;(2-hydroxy phenyl)acetic acid benzyl ester;(2-Hydroxy-phenyl)-acetic acid benzyl ester;benzyl [(2-hydroxy)phenyl]acetate;benzyl 2-hydroxyphenylacetate;benzyl 2-(2-hydroxyphenyl)acetate;(2-hydroxyphenyl)acetic acid benzyl ester
• CAS NO: 19829-38-0
• Molecular Formula: C15H14O3
• Molecular Weight: 242.274
• Mol File: 19829-38-0.mol
• Article Data: 7

Chemical Properties

• Melting Point: 98 - 100 °C (cyclohexane)
• CAS DataBase Reference: Benzeneacetic acid, 2-hydroxy-, phenylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzeneacetic acid, 2-hydroxy-, phenylmethyl ester(19829-38-0)
• EPA Substance Registry System: Benzeneacetic acid, 2-hydroxy-, phenylmethyl ester(19829-38-0)

Safety Data

• Hazardous Substances Data: 19829-38-0(Hazardous Substances Data)

Upstream product

• 22446-37-3 methyl (2-hydroxyphenyl)acetate 
• 100-51-6 benzyl alcohol 
• 70340-04-4 (2-hydroxybenzyl)triphenylphosphonium bromide 
• 501-53-1 benzyl chloroformate 
• 100-39-0 benzyl bromide 
• 614-75-5 2-Hydroxyphenylacetic acid 
• 108-20-3 di-isopropyl ether 
• 104-15-4 toluene-4-sulfonic acid 

Downstream Products

• 787619-56-1 [2-(2-Diethylaminoethoxy)phenyl]acetic acid benzyl ester 
• 1191257-51-8 (3R,4S,Z)-benzyl 2-benzylidene-3-phenylchroman-4-carboxylate 
• 787620-76-2 [2-(2-morpholin-4-yl-ethoxy)-phenyl]-acetic acid 
• 787619-57-2 [2-(2-morpholin-4-yl-ethoxy)-phenyl]-acetic acid benzyl ester 

Relevant articles and documents

AROMATIC SULFONAMIDE DERIVATIVES

Substituted aromatic sulfonamides of formula (I) pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease.

NOVEL COMPOUNDS AND THEIR USE IN THERAPY

The invention provides compounds which inhibit N-myristoyltransferase and are selective for protozoal N-myristoyltransferase and, consequently suitable to treat microbial infections, including viral and fungal infections, and protozoan infections such as malaria, leishmaniasis and sleeping sickness.

PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease

The invention provides compounds of Formula (I) the stereoisomers and prodrugs thereof, and the pharmaceutically acceptable salts of the compounds, stereoisomers, and prodrugs, wherein A, P, J, x, and R10 are as defined herein; pharmaceutical compositions thereof; and methods of using the pharmaceutical compositions for the treatment of diseases, including, diabetes, including type 1 and type 2 diabetes, hyperglycemia, dyslipidemia, impaired glucose tolerance, metabolic syndrome, and/or cardiovascular disease.